nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—CYP2C9—brain cancer	0.491	1	CbGaD
Fluvastatin—UGT1A1—Etoposide—brain cancer	0.0648	0.195	CbGbCtD
Fluvastatin—CYP2D6—Lomustine—brain cancer	0.0501	0.151	CbGbCtD
Fluvastatin—CYP1A2—Carmustine—brain cancer	0.0496	0.149	CbGbCtD
Fluvastatin—CYP2D6—Hydroxyurea—brain cancer	0.038	0.114	CbGbCtD
Fluvastatin—CYP3A4—Temozolomide—brain cancer	0.0375	0.113	CbGbCtD
Fluvastatin—CYP3A4—Lomustine—brain cancer	0.0319	0.0957	CbGbCtD
Fluvastatin—CYP3A5—Etoposide—brain cancer	0.0197	0.0593	CbGbCtD
Fluvastatin—CYP2C8—Etoposide—brain cancer	0.019	0.057	CbGbCtD
Fluvastatin—CYP1A2—Etoposide—brain cancer	0.0147	0.0441	CbGbCtD
Fluvastatin—CYP3A4—Etoposide—brain cancer	0.0077	0.0231	CbGbCtD
Fluvastatin—Rosuvastatin—CYP2C9—brain cancer	0.00193	0.388	CrCbGaD
Fluvastatin—Pitavastatin—CYP2C9—brain cancer	0.00168	0.339	CrCbGaD
Fluvastatin—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00151	0.0295	CbGpPWpGaD
Fluvastatin—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00148	0.0289	CbGpPWpGaD
Fluvastatin—UGT2B7—Tamoxifen metabolism—CYP2C9—brain cancer	0.00147	0.0286	CbGpPWpGaD
Fluvastatin—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00136	0.0265	CbGpPWpGaD
Fluvastatin—Atorvastatin—CYP2C9—brain cancer	0.00136	0.273	CrCbGaD
Fluvastatin—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00135	0.0263	CbGpPWpGaD
Fluvastatin—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00124	0.0243	CbGpPWpGaD
Fluvastatin—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00124	0.0241	CbGpPWpGaD
Fluvastatin—UGT1A3—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00123	0.024	CbGpPWpGaD
Fluvastatin—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00121	0.0237	CbGpPWpGaD
Fluvastatin—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.0011	0.0215	CbGpPWpGaD
Fluvastatin—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00105	0.0206	CbGpPWpGaD
Fluvastatin—HMGCR—SREBF and miR33 in cholesterol and lipid homeostasis—SIRT1—brain cancer	0.000981	0.0191	CbGpPWpGaD
Fluvastatin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000946	0.0184	CbGpPWpGaD
Fluvastatin—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000941	0.0183	CbGpPWpGaD
Fluvastatin—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000865	0.0169	CbGpPWpGaD
Fluvastatin—HMGCR—AMPK Signaling—STRADA—brain cancer	0.000863	0.0168	CbGpPWpGaD
Fluvastatin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000861	0.0168	CbGpPWpGaD
Fluvastatin—UGT1A1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000852	0.0166	CbGpPWpGaD
Fluvastatin—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000772	0.0151	CbGpPWpGaD
Fluvastatin—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000754	0.0147	CbGpPWpGaD
Fluvastatin—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000725	0.0141	CbGpPWpGaD
Fluvastatin—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.000712	0.0139	CbGpPWpGaD
Fluvastatin—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000685	0.0134	CbGpPWpGaD
Fluvastatin—SLCO2B1—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000678	0.0132	CbGpPWpGaD
Fluvastatin—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000653	0.0127	CbGpPWpGaD
Fluvastatin—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000628	0.0123	CbGpPWpGaD
Fluvastatin—SLCO2B1—ganglion—brain cancer	0.000609	0.0755	CbGeAlD
Fluvastatin—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000583	0.0114	CbGpPWpGaD
Fluvastatin—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000561	0.0109	CbGpPWpGaD
Fluvastatin—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000536	0.0105	CbGpPWpGaD
Fluvastatin—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00053	0.0103	CbGpPWpGaD
Fluvastatin—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000518	0.0101	CbGpPWpGaD
Fluvastatin—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000516	0.0101	CbGpPWpGaD
Fluvastatin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000505	0.00985	CbGpPWpGaD
Fluvastatin—Tremor—Procarbazine—brain cancer	0.000461	0.00411	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000461	0.00411	CcSEcCtD
Fluvastatin—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000454	0.00886	CbGpPWpGaD
Fluvastatin—Muscular weakness—Carmustine—brain cancer	0.000451	0.00402	CcSEcCtD
Fluvastatin—Breast disorder—Temozolomide—brain cancer	0.000446	0.00398	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000445	0.00397	CcSEcCtD
Fluvastatin—Syncope—Procarbazine—brain cancer	0.000441	0.00394	CcSEcCtD
Fluvastatin—Leukopenia—Procarbazine—brain cancer	0.00044	0.00393	CcSEcCtD
Fluvastatin—UGT1A1—Irinotecan Pathway—APC—brain cancer	0.000438	0.00854	CbGpPWpGaD
Fluvastatin—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000437	0.00852	CbGpPWpGaD
Fluvastatin—Muscular weakness—Temozolomide—brain cancer	0.000436	0.00389	CcSEcCtD
Fluvastatin—Loss of consciousness—Procarbazine—brain cancer	0.000432	0.00386	CcSEcCtD
Fluvastatin—Cough—Procarbazine—brain cancer	0.000429	0.00383	CcSEcCtD
Fluvastatin—Hypertension—Procarbazine—brain cancer	0.000425	0.00379	CcSEcCtD
Fluvastatin—Myalgia—Procarbazine—brain cancer	0.000419	0.00374	CcSEcCtD
Fluvastatin—Arthralgia—Procarbazine—brain cancer	0.000419	0.00374	CcSEcCtD
Fluvastatin—Anxiety—Procarbazine—brain cancer	0.000417	0.00373	CcSEcCtD
Fluvastatin—UGT1A3—endocrine gland—brain cancer	0.000412	0.0511	CbGeAlD
Fluvastatin—Bronchitis—Temozolomide—brain cancer	0.000411	0.00366	CcSEcCtD
Fluvastatin—Confusional state—Procarbazine—brain cancer	0.000405	0.00361	CcSEcCtD
Fluvastatin—Vomiting—Lomustine—brain cancer	0.000402	0.00359	CcSEcCtD
Fluvastatin—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.000401	0.00782	CbGpPWpGaD
Fluvastatin—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.0004	0.00781	CbGpPWpGaD
Fluvastatin—Infection—Procarbazine—brain cancer	0.000399	0.00356	CcSEcCtD
Fluvastatin—Angiopathy—Hydroxyurea—brain cancer	0.000397	0.00354	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Temozolomide—brain cancer	0.000397	0.00354	CcSEcCtD
Fluvastatin—Shock—Procarbazine—brain cancer	0.000395	0.00353	CcSEcCtD
Fluvastatin—Erectile dysfunction—Temozolomide—brain cancer	0.000393	0.00351	CcSEcCtD
Fluvastatin—Thrombocytopenia—Procarbazine—brain cancer	0.000393	0.00351	CcSEcCtD
Fluvastatin—Chills—Hydroxyurea—brain cancer	0.000393	0.0035	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Temozolomide—brain cancer	0.00039	0.00348	CcSEcCtD
Fluvastatin—Hyperhidrosis—Procarbazine—brain cancer	0.000388	0.00346	CcSEcCtD
Fluvastatin—Alopecia—Hydroxyurea—brain cancer	0.000387	0.00345	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Carmustine—brain cancer	0.000386	0.00345	CcSEcCtD
Fluvastatin—Urinary tract infection—Carmustine—brain cancer	0.000383	0.00342	CcSEcCtD
Fluvastatin—Anorexia—Procarbazine—brain cancer	0.000383	0.00342	CcSEcCtD
Fluvastatin—Erythema—Hydroxyurea—brain cancer	0.000381	0.0034	CcSEcCtD
Fluvastatin—Infestation NOS—Temozolomide—brain cancer	0.000381	0.0034	CcSEcCtD
Fluvastatin—Infestation—Temozolomide—brain cancer	0.000381	0.0034	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000377	0.00337	CcSEcCtD
Fluvastatin—Nausea—Lomustine—brain cancer	0.000376	0.00335	CcSEcCtD
Fluvastatin—SLCO1B3—pituitary gland—brain cancer	0.000374	0.0464	CbGeAlD
Fluvastatin—Neuropathy peripheral—Temozolomide—brain cancer	0.000373	0.00333	CcSEcCtD
Fluvastatin—Urinary tract infection—Temozolomide—brain cancer	0.00037	0.0033	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000366	0.00327	CcSEcCtD
Fluvastatin—Insomnia—Procarbazine—brain cancer	0.000363	0.00324	CcSEcCtD
Fluvastatin—Paraesthesia—Procarbazine—brain cancer	0.000361	0.00322	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Temozolomide—brain cancer	0.00036	0.00321	CcSEcCtD
Fluvastatin—Sinusitis—Temozolomide—brain cancer	0.000357	0.00319	CcSEcCtD
Fluvastatin—Cramp muscle—Etoposide—brain cancer	0.000356	0.00318	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000356	0.00318	CcSEcCtD
Fluvastatin—Ill-defined disorder—Hydroxyurea—brain cancer	0.000353	0.00315	CcSEcCtD
Fluvastatin—Hypoaesthesia—Carmustine—brain cancer	0.000352	0.00314	CcSEcCtD
Fluvastatin—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000351	0.00684	CbGpPWpGaD
Fluvastatin—Decreased appetite—Procarbazine—brain cancer	0.000349	0.00312	CcSEcCtD
Fluvastatin—Oedema peripheral—Carmustine—brain cancer	0.000348	0.00311	CcSEcCtD
Fluvastatin—Connective tissue disorder—Carmustine—brain cancer	0.000348	0.0031	CcSEcCtD
Fluvastatin—Fatigue—Procarbazine—brain cancer	0.000346	0.00309	CcSEcCtD
Fluvastatin—Malaise—Hydroxyurea—brain cancer	0.000343	0.00306	CcSEcCtD
Fluvastatin—Pain—Procarbazine—brain cancer	0.000343	0.00306	CcSEcCtD
Fluvastatin—Constipation—Procarbazine—brain cancer	0.000343	0.00306	CcSEcCtD
Fluvastatin—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000342	0.00668	CbGpPWpGaD
Fluvastatin—Hepatitis—Temozolomide—brain cancer	0.000342	0.00305	CcSEcCtD
Fluvastatin—Leukopenia—Hydroxyurea—brain cancer	0.000341	0.00304	CcSEcCtD
Fluvastatin—Visual impairment—Carmustine—brain cancer	0.000341	0.00304	CcSEcCtD
Fluvastatin—Hypoaesthesia—Temozolomide—brain cancer	0.00034	0.00303	CcSEcCtD
Fluvastatin—Pharyngitis—Temozolomide—brain cancer	0.000339	0.00303	CcSEcCtD
Fluvastatin—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000337	0.00658	CbGpPWpGaD
Fluvastatin—Oedema peripheral—Temozolomide—brain cancer	0.000337	0.003	CcSEcCtD
Fluvastatin—Connective tissue disorder—Temozolomide—brain cancer	0.000336	0.003	CcSEcCtD
Fluvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000331	0.00646	CbGpPWpGaD
Fluvastatin—Feeling abnormal—Procarbazine—brain cancer	0.000331	0.00295	CcSEcCtD
Fluvastatin—Visual impairment—Temozolomide—brain cancer	0.000329	0.00294	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Procarbazine—brain cancer	0.000328	0.00293	CcSEcCtD
Fluvastatin—Flushing—Carmustine—brain cancer	0.000328	0.00293	CcSEcCtD
Fluvastatin—Erythema multiforme—Temozolomide—brain cancer	0.000323	0.00288	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000322	0.00287	CcSEcCtD
Fluvastatin—UGT1A3—Biological oxidations—CYP2C9—brain cancer	0.000321	0.00626	CbGpPWpGaD
Fluvastatin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00032	0.00625	CbGpPWpGaD
Fluvastatin—Discomfort—Hydroxyurea—brain cancer	0.00032	0.00286	CcSEcCtD
Fluvastatin—Urticaria—Procarbazine—brain cancer	0.000319	0.00285	CcSEcCtD
Fluvastatin—Body temperature increased—Procarbazine—brain cancer	0.000317	0.00283	CcSEcCtD
Fluvastatin—Abdominal pain—Procarbazine—brain cancer	0.000317	0.00283	CcSEcCtD
Fluvastatin—Flushing—Temozolomide—brain cancer	0.000317	0.00283	CcSEcCtD
Fluvastatin—Cardiac disorder—Temozolomide—brain cancer	0.000317	0.00283	CcSEcCtD
Fluvastatin—UGT1A3—Metapathway biotransformation—CYP2C9—brain cancer	0.000317	0.00618	CbGpPWpGaD
Fluvastatin—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000316	0.00617	CbGpPWpGaD
Fluvastatin—Arrhythmia—Carmustine—brain cancer	0.000316	0.00282	CcSEcCtD
Fluvastatin—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000314	0.00612	CbGpPWpGaD
Fluvastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000313	0.00611	CbGpPWpGaD
Fluvastatin—Alopecia—Carmustine—brain cancer	0.000312	0.00279	CcSEcCtD
Fluvastatin—Angiopathy—Temozolomide—brain cancer	0.00031	0.00277	CcSEcCtD
Fluvastatin—Mental disorder—Carmustine—brain cancer	0.00031	0.00277	CcSEcCtD
Fluvastatin—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000309	0.00603	CbGpPWpGaD
Fluvastatin—Infection—Hydroxyurea—brain cancer	0.000309	0.00276	CcSEcCtD
Fluvastatin—Immune system disorder—Temozolomide—brain cancer	0.000309	0.00275	CcSEcCtD
Fluvastatin—Erythema—Carmustine—brain cancer	0.000308	0.00275	CcSEcCtD
Fluvastatin—Chills—Temozolomide—brain cancer	0.000307	0.00274	CcSEcCtD
Fluvastatin—Nervous system disorder—Hydroxyurea—brain cancer	0.000305	0.00272	CcSEcCtD
Fluvastatin—Infestation—Etoposide—brain cancer	0.000305	0.00272	CcSEcCtD
Fluvastatin—Infestation NOS—Etoposide—brain cancer	0.000305	0.00272	CcSEcCtD
Fluvastatin—HMGCR—SREBP signalling—SIRT1—brain cancer	0.000305	0.00594	CbGpPWpGaD
Fluvastatin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000304	0.00272	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000302	0.0027	CcSEcCtD
Fluvastatin—Alopecia—Temozolomide—brain cancer	0.000302	0.0027	CcSEcCtD
Fluvastatin—Skin disorder—Hydroxyurea—brain cancer	0.000302	0.00269	CcSEcCtD
Fluvastatin—Mental disorder—Temozolomide—brain cancer	0.000299	0.00267	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Etoposide—brain cancer	0.000299	0.00267	CcSEcCtD
Fluvastatin—Back pain—Carmustine—brain cancer	0.000298	0.00266	CcSEcCtD
Fluvastatin—Erythema—Temozolomide—brain cancer	0.000297	0.00266	CcSEcCtD
Fluvastatin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000297	0.0058	CbGpPWpGaD
Fluvastatin—Anorexia—Hydroxyurea—brain cancer	0.000296	0.00264	CcSEcCtD
Fluvastatin—Hypersensitivity—Procarbazine—brain cancer	0.000296	0.00264	CcSEcCtD
Fluvastatin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000296	0.00577	CbGpPWpGaD
Fluvastatin—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000292	0.0057	CbGpPWpGaD
Fluvastatin—Dysgeusia—Temozolomide—brain cancer	0.000291	0.0026	CcSEcCtD
Fluvastatin—SLCO1B3—endocrine gland—brain cancer	0.00029	0.0359	CbGeAlD
Fluvastatin—Tremor—Carmustine—brain cancer	0.000288	0.00257	CcSEcCtD
Fluvastatin—Asthenia—Procarbazine—brain cancer	0.000288	0.00257	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Etoposide—brain cancer	0.000288	0.00257	CcSEcCtD
Fluvastatin—Back pain—Temozolomide—brain cancer	0.000288	0.00257	CcSEcCtD
Fluvastatin—Pruritus—Procarbazine—brain cancer	0.000284	0.00254	CcSEcCtD
Fluvastatin—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00028	0.00546	CbGpPWpGaD
Fluvastatin—Tremor—Temozolomide—brain cancer	0.000279	0.00249	CcSEcCtD
Fluvastatin—HMGCR—telencephalon—brain cancer	0.000277	0.0344	CbGeAlD
Fluvastatin—Dyspnoea—Hydroxyurea—brain cancer	0.000277	0.00247	CcSEcCtD
Fluvastatin—Ill-defined disorder—Temozolomide—brain cancer	0.000276	0.00246	CcSEcCtD
Fluvastatin—Leukopenia—Carmustine—brain cancer	0.000276	0.00246	CcSEcCtD
Fluvastatin—Diarrhoea—Procarbazine—brain cancer	0.000275	0.00245	CcSEcCtD
Fluvastatin—Dyspepsia—Hydroxyurea—brain cancer	0.000274	0.00244	CcSEcCtD
Fluvastatin—UGT2B7—Biological oxidations—CYP2C9—brain cancer	0.000273	0.00533	CbGpPWpGaD
Fluvastatin—Hypoaesthesia—Etoposide—brain cancer	0.000272	0.00243	CcSEcCtD
Fluvastatin—Angioedema—Temozolomide—brain cancer	0.000272	0.00243	CcSEcCtD
Fluvastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000271	0.00529	CbGpPWpGaD
Fluvastatin—Decreased appetite—Hydroxyurea—brain cancer	0.00027	0.00241	CcSEcCtD
Fluvastatin—UGT2B7—Metapathway biotransformation—CYP2C9—brain cancer	0.000269	0.00525	CbGpPWpGaD
Fluvastatin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000268	0.00239	CcSEcCtD
Fluvastatin—Malaise—Temozolomide—brain cancer	0.000268	0.00239	CcSEcCtD
Fluvastatin—Fatigue—Hydroxyurea—brain cancer	0.000268	0.00239	CcSEcCtD
Fluvastatin—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000268	0.00522	CbGpPWpGaD
Fluvastatin—Vertigo—Temozolomide—brain cancer	0.000267	0.00239	CcSEcCtD
Fluvastatin—Leukopenia—Temozolomide—brain cancer	0.000266	0.00238	CcSEcCtD
Fluvastatin—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000266	0.00519	CbGpPWpGaD
Fluvastatin—Hypertension—Carmustine—brain cancer	0.000266	0.00237	CcSEcCtD
Fluvastatin—Pain—Hydroxyurea—brain cancer	0.000266	0.00237	CcSEcCtD
Fluvastatin—Constipation—Hydroxyurea—brain cancer	0.000266	0.00237	CcSEcCtD
Fluvastatin—Dizziness—Procarbazine—brain cancer	0.000266	0.00237	CcSEcCtD
Fluvastatin—Myalgia—Carmustine—brain cancer	0.000262	0.00234	CcSEcCtD
Fluvastatin—Chest pain—Carmustine—brain cancer	0.000262	0.00234	CcSEcCtD
Fluvastatin—Anxiety—Carmustine—brain cancer	0.000261	0.00233	CcSEcCtD
Fluvastatin—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00026	0.00507	CbGpPWpGaD
Fluvastatin—Cough—Temozolomide—brain cancer	0.00026	0.00232	CcSEcCtD
Fluvastatin—Erythema multiforme—Etoposide—brain cancer	0.000259	0.00231	CcSEcCtD
Fluvastatin—Hypertension—Temozolomide—brain cancer	0.000257	0.00229	CcSEcCtD
Fluvastatin—Feeling abnormal—Hydroxyurea—brain cancer	0.000256	0.00229	CcSEcCtD
Fluvastatin—Vomiting—Procarbazine—brain cancer	0.000255	0.00228	CcSEcCtD
Fluvastatin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000254	0.00495	CbGpPWpGaD
Fluvastatin—Flushing—Etoposide—brain cancer	0.000254	0.00227	CcSEcCtD
Fluvastatin—Cardiac disorder—Etoposide—brain cancer	0.000254	0.00227	CcSEcCtD
Fluvastatin—Confusional state—Carmustine—brain cancer	0.000253	0.00226	CcSEcCtD
Fluvastatin—Arthralgia—Temozolomide—brain cancer	0.000253	0.00226	CcSEcCtD
Fluvastatin—Myalgia—Temozolomide—brain cancer	0.000253	0.00226	CcSEcCtD
Fluvastatin—Rash—Procarbazine—brain cancer	0.000253	0.00226	CcSEcCtD
Fluvastatin—Dermatitis—Procarbazine—brain cancer	0.000253	0.00226	CcSEcCtD
Fluvastatin—Anxiety—Temozolomide—brain cancer	0.000252	0.00225	CcSEcCtD
Fluvastatin—Headache—Procarbazine—brain cancer	0.000252	0.00225	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000252	0.00224	CcSEcCtD
Fluvastatin—Discomfort—Temozolomide—brain cancer	0.00025	0.00223	CcSEcCtD
Fluvastatin—Infection—Carmustine—brain cancer	0.00025	0.00223	CcSEcCtD
Fluvastatin—Angiopathy—Etoposide—brain cancer	0.000248	0.00221	CcSEcCtD
Fluvastatin—Immune system disorder—Etoposide—brain cancer	0.000247	0.0022	CcSEcCtD
Fluvastatin—Thrombocytopenia—Carmustine—brain cancer	0.000246	0.0022	CcSEcCtD
Fluvastatin—Body temperature increased—Hydroxyurea—brain cancer	0.000246	0.00219	CcSEcCtD
Fluvastatin—Chills—Etoposide—brain cancer	0.000245	0.00219	CcSEcCtD
Fluvastatin—Confusional state—Temozolomide—brain cancer	0.000245	0.00218	CcSEcCtD
Fluvastatin—Anaphylactic shock—Temozolomide—brain cancer	0.000243	0.00217	CcSEcCtD
Fluvastatin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000242	0.00472	CbGpPWpGaD
Fluvastatin—Alopecia—Etoposide—brain cancer	0.000242	0.00216	CcSEcCtD
Fluvastatin—Infection—Temozolomide—brain cancer	0.000241	0.00215	CcSEcCtD
Fluvastatin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000241	0.0047	CbGpPWpGaD
Fluvastatin—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00024	0.00468	CbGpPWpGaD
Fluvastatin—Anorexia—Carmustine—brain cancer	0.000239	0.00214	CcSEcCtD
Fluvastatin—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000239	0.00466	CbGpPWpGaD
Fluvastatin—Nausea—Procarbazine—brain cancer	0.000239	0.00213	CcSEcCtD
Fluvastatin—Nervous system disorder—Temozolomide—brain cancer	0.000238	0.00213	CcSEcCtD
Fluvastatin—Thrombocytopenia—Temozolomide—brain cancer	0.000238	0.00212	CcSEcCtD
Fluvastatin—UGT2B7—endocrine gland—brain cancer	0.000237	0.0294	CbGeAlD
Fluvastatin—Skin disorder—Temozolomide—brain cancer	0.000236	0.0021	CcSEcCtD
Fluvastatin—SLCO2B1—telencephalon—brain cancer	0.000235	0.0291	CbGeAlD
Fluvastatin—Hyperhidrosis—Temozolomide—brain cancer	0.000235	0.00209	CcSEcCtD
Fluvastatin—Dysgeusia—Etoposide—brain cancer	0.000233	0.00208	CcSEcCtD
Fluvastatin—Anorexia—Temozolomide—brain cancer	0.000231	0.00207	CcSEcCtD
Fluvastatin—HMGCR—gonad—brain cancer	0.000231	0.0287	CbGeAlD
Fluvastatin—Back pain—Etoposide—brain cancer	0.00023	0.00206	CcSEcCtD
Fluvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000229	0.00447	CbGpPWpGaD
Fluvastatin—Hypersensitivity—Hydroxyurea—brain cancer	0.000229	0.00204	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000229	0.00204	CcSEcCtD
Fluvastatin—Muscle spasms—Etoposide—brain cancer	0.000229	0.00204	CcSEcCtD
Fluvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000229	0.00446	CbGpPWpGaD
Fluvastatin—Insomnia—Carmustine—brain cancer	0.000227	0.00203	CcSEcCtD
Fluvastatin—HMGCR—pituitary gland—brain cancer	0.000226	0.028	CbGeAlD
Fluvastatin—Paraesthesia—Carmustine—brain cancer	0.000226	0.00201	CcSEcCtD
Fluvastatin—Dyspnoea—Carmustine—brain cancer	0.000224	0.002	CcSEcCtD
Fluvastatin—Asthenia—Hydroxyurea—brain cancer	0.000223	0.00199	CcSEcCtD
Fluvastatin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000223	0.00434	CbGpPWpGaD
Fluvastatin—UGT1A1—Biological oxidations—CYP2C9—brain cancer	0.000222	0.00433	CbGpPWpGaD
Fluvastatin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000221	0.00197	CcSEcCtD
Fluvastatin—Ill-defined disorder—Etoposide—brain cancer	0.000221	0.00197	CcSEcCtD
Fluvastatin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00022	0.00429	CbGpPWpGaD
Fluvastatin—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00022	0.00429	CbGpPWpGaD
Fluvastatin—Insomnia—Temozolomide—brain cancer	0.00022	0.00196	CcSEcCtD
Fluvastatin—UGT1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000219	0.00427	CbGpPWpGaD
Fluvastatin—Decreased appetite—Carmustine—brain cancer	0.000218	0.00195	CcSEcCtD
Fluvastatin—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000218	0.00426	CbGpPWpGaD
Fluvastatin—Paraesthesia—Temozolomide—brain cancer	0.000218	0.00195	CcSEcCtD
Fluvastatin—HMGCR—medulla oblongata—brain cancer	0.000218	0.027	CbGeAlD
Fluvastatin—Gastrointestinal disorder—Carmustine—brain cancer	0.000217	0.00194	CcSEcCtD
Fluvastatin—HMGCR—AMPK Signaling—PIK3CG—brain cancer	0.000217	0.00423	CbGpPWpGaD
Fluvastatin—Dyspnoea—Temozolomide—brain cancer	0.000216	0.00193	CcSEcCtD
Fluvastatin—Pain—Carmustine—brain cancer	0.000215	0.00192	CcSEcCtD
Fluvastatin—Constipation—Carmustine—brain cancer	0.000215	0.00192	CcSEcCtD
Fluvastatin—Malaise—Etoposide—brain cancer	0.000215	0.00192	CcSEcCtD
Fluvastatin—Vertigo—Etoposide—brain cancer	0.000214	0.00191	CcSEcCtD
Fluvastatin—Dyspepsia—Temozolomide—brain cancer	0.000214	0.00191	CcSEcCtD
Fluvastatin—Leukopenia—Etoposide—brain cancer	0.000213	0.0019	CcSEcCtD
Fluvastatin—Diarrhoea—Hydroxyurea—brain cancer	0.000213	0.0019	CcSEcCtD
Fluvastatin—Decreased appetite—Temozolomide—brain cancer	0.000211	0.00188	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Temozolomide—brain cancer	0.00021	0.00187	CcSEcCtD
Fluvastatin—Fatigue—Temozolomide—brain cancer	0.000209	0.00187	CcSEcCtD
Fluvastatin—Loss of consciousness—Etoposide—brain cancer	0.000209	0.00187	CcSEcCtD
Fluvastatin—Cough—Etoposide—brain cancer	0.000208	0.00185	CcSEcCtD
Fluvastatin—Pain—Temozolomide—brain cancer	0.000208	0.00185	CcSEcCtD
Fluvastatin—Constipation—Temozolomide—brain cancer	0.000208	0.00185	CcSEcCtD
Fluvastatin—Feeling abnormal—Carmustine—brain cancer	0.000207	0.00185	CcSEcCtD
Fluvastatin—Hypertension—Etoposide—brain cancer	0.000206	0.00183	CcSEcCtD
Fluvastatin—Dizziness—Hydroxyurea—brain cancer	0.000206	0.00183	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Carmustine—brain cancer	0.000205	0.00183	CcSEcCtD
Fluvastatin—Chest pain—Etoposide—brain cancer	0.000203	0.00181	CcSEcCtD
Fluvastatin—UGT1A1—endocrine gland—brain cancer	0.000201	0.025	CbGeAlD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000201	0.0018	CcSEcCtD
Fluvastatin—Discomfort—Etoposide—brain cancer	0.0002	0.00179	CcSEcCtD
Fluvastatin—Feeling abnormal—Temozolomide—brain cancer	0.0002	0.00179	CcSEcCtD
Fluvastatin—HMGCR—midbrain—brain cancer	0.000199	0.0247	CbGeAlD
Fluvastatin—Abdominal pain—Carmustine—brain cancer	0.000199	0.00177	CcSEcCtD
Fluvastatin—Body temperature increased—Carmustine—brain cancer	0.000199	0.00177	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Temozolomide—brain cancer	0.000199	0.00177	CcSEcCtD
Fluvastatin—CYP2D6—hindbrain—brain cancer	0.000198	0.0246	CbGeAlD
Fluvastatin—Vomiting—Hydroxyurea—brain cancer	0.000198	0.00176	CcSEcCtD
Fluvastatin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000196	0.00383	CbGpPWpGaD
Fluvastatin—Rash—Hydroxyurea—brain cancer	0.000196	0.00175	CcSEcCtD
Fluvastatin—Confusional state—Etoposide—brain cancer	0.000196	0.00175	CcSEcCtD
Fluvastatin—Dermatitis—Hydroxyurea—brain cancer	0.000196	0.00175	CcSEcCtD
Fluvastatin—Headache—Hydroxyurea—brain cancer	0.000195	0.00174	CcSEcCtD
Fluvastatin—Anaphylactic shock—Etoposide—brain cancer	0.000194	0.00173	CcSEcCtD
Fluvastatin—HMGCR—spinal cord—brain cancer	0.000194	0.0241	CbGeAlD
Fluvastatin—Infection—Etoposide—brain cancer	0.000193	0.00172	CcSEcCtD
Fluvastatin—Urticaria—Temozolomide—brain cancer	0.000193	0.00172	CcSEcCtD
Fluvastatin—Abdominal pain—Temozolomide—brain cancer	0.000192	0.00171	CcSEcCtD
Fluvastatin—Body temperature increased—Temozolomide—brain cancer	0.000192	0.00171	CcSEcCtD
Fluvastatin—Thrombocytopenia—Etoposide—brain cancer	0.00019	0.0017	CcSEcCtD
Fluvastatin—Skin disorder—Etoposide—brain cancer	0.000189	0.00168	CcSEcCtD
Fluvastatin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000189	0.00368	CbGpPWpGaD
Fluvastatin—Hyperhidrosis—Etoposide—brain cancer	0.000188	0.00168	CcSEcCtD
Fluvastatin—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000186	0.00363	CbGpPWpGaD
Fluvastatin—Anorexia—Etoposide—brain cancer	0.000185	0.00165	CcSEcCtD
Fluvastatin—Hypersensitivity—Carmustine—brain cancer	0.000185	0.00165	CcSEcCtD
Fluvastatin—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000185	0.0036	CbGpPWpGaD
Fluvastatin—Nausea—Hydroxyurea—brain cancer	0.000185	0.00165	CcSEcCtD
Fluvastatin—SLCO2B1—medulla oblongata—brain cancer	0.000185	0.0229	CbGeAlD
Fluvastatin—SLC15A1—endocrine gland—brain cancer	0.000181	0.0225	CbGeAlD
Fluvastatin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000181	0.00352	CbGpPWpGaD
Fluvastatin—Asthenia—Carmustine—brain cancer	0.00018	0.00161	CcSEcCtD
Fluvastatin—Hypersensitivity—Temozolomide—brain cancer	0.000179	0.0016	CcSEcCtD
Fluvastatin—HMGCR—endocrine gland—brain cancer	0.000175	0.0217	CbGeAlD
Fluvastatin—Paraesthesia—Etoposide—brain cancer	0.000174	0.00156	CcSEcCtD
Fluvastatin—Asthenia—Temozolomide—brain cancer	0.000174	0.00155	CcSEcCtD
Fluvastatin—Dyspnoea—Etoposide—brain cancer	0.000173	0.00155	CcSEcCtD
Fluvastatin—HMGCR—head—brain cancer	0.000173	0.0214	CbGeAlD
Fluvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000172	0.00336	CbGpPWpGaD
Fluvastatin—Diarrhoea—Carmustine—brain cancer	0.000172	0.00153	CcSEcCtD
Fluvastatin—Pruritus—Temozolomide—brain cancer	0.000172	0.00153	CcSEcCtD
Fluvastatin—SLCO2B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000171	0.00333	CbGpPWpGaD
Fluvastatin—Decreased appetite—Etoposide—brain cancer	0.000169	0.00151	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Etoposide—brain cancer	0.000168	0.0015	CcSEcCtD
Fluvastatin—SLCO1B1—endocrine gland—brain cancer	0.000168	0.0208	CbGeAlD
Fluvastatin—Fatigue—Etoposide—brain cancer	0.000168	0.00149	CcSEcCtD
Fluvastatin—Dizziness—Carmustine—brain cancer	0.000166	0.00148	CcSEcCtD
Fluvastatin—Constipation—Etoposide—brain cancer	0.000166	0.00148	CcSEcCtD
Fluvastatin—Pain—Etoposide—brain cancer	0.000166	0.00148	CcSEcCtD
Fluvastatin—Diarrhoea—Temozolomide—brain cancer	0.000166	0.00148	CcSEcCtD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000166	0.00324	CbGpPWpGaD
Fluvastatin—SLCO2B1—spinal cord—brain cancer	0.000165	0.0204	CbGeAlD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000163	0.00318	CbGpPWpGaD
Fluvastatin—Dizziness—Temozolomide—brain cancer	0.000161	0.00143	CcSEcCtD
Fluvastatin—Feeling abnormal—Etoposide—brain cancer	0.00016	0.00143	CcSEcCtD
Fluvastatin—Vomiting—Carmustine—brain cancer	0.00016	0.00143	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Etoposide—brain cancer	0.000159	0.00142	CcSEcCtD
Fluvastatin—Rash—Carmustine—brain cancer	0.000158	0.00141	CcSEcCtD
Fluvastatin—Dermatitis—Carmustine—brain cancer	0.000158	0.00141	CcSEcCtD
Fluvastatin—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000158	0.00308	CbGpPWpGaD
Fluvastatin—HMGCR—central nervous system—brain cancer	0.000158	0.0195	CbGeAlD
Fluvastatin—Headache—Carmustine—brain cancer	0.000157	0.0014	CcSEcCtD
Fluvastatin—Vomiting—Temozolomide—brain cancer	0.000154	0.00138	CcSEcCtD
Fluvastatin—Urticaria—Etoposide—brain cancer	0.000154	0.00138	CcSEcCtD
Fluvastatin—HMGCR—cerebellum—brain cancer	0.000154	0.0191	CbGeAlD
Fluvastatin—Body temperature increased—Etoposide—brain cancer	0.000154	0.00137	CcSEcCtD
Fluvastatin—Abdominal pain—Etoposide—brain cancer	0.000154	0.00137	CcSEcCtD
Fluvastatin—Rash—Temozolomide—brain cancer	0.000153	0.00137	CcSEcCtD
Fluvastatin—Dermatitis—Temozolomide—brain cancer	0.000153	0.00137	CcSEcCtD
Fluvastatin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000153	0.00298	CbGpPWpGaD
Fluvastatin—Headache—Temozolomide—brain cancer	0.000152	0.00136	CcSEcCtD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000151	0.00295	CbGpPWpGaD
Fluvastatin—Nausea—Carmustine—brain cancer	0.000149	0.00133	CcSEcCtD
Fluvastatin—SLCO2B1—endocrine gland—brain cancer	0.000148	0.0184	CbGeAlD
Fluvastatin—SLCO2B1—head—brain cancer	0.000146	0.0181	CbGeAlD
Fluvastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000146	0.00284	CbGpPWpGaD
Fluvastatin—Nausea—Temozolomide—brain cancer	0.000144	0.00129	CcSEcCtD
Fluvastatin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000144	0.0028	CbGpPWpGaD
Fluvastatin—Hypersensitivity—Etoposide—brain cancer	0.000143	0.00128	CcSEcCtD
Fluvastatin—Asthenia—Etoposide—brain cancer	0.000139	0.00124	CcSEcCtD
Fluvastatin—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000138	0.00269	CbGpPWpGaD
Fluvastatin—Pruritus—Etoposide—brain cancer	0.000137	0.00123	CcSEcCtD
Fluvastatin—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000136	0.00265	CbGpPWpGaD
Fluvastatin—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000135	0.00263	CbGpPWpGaD
Fluvastatin—SLCO2B1—central nervous system—brain cancer	0.000134	0.0166	CbGeAlD
Fluvastatin—SLCO1B3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000133	0.0026	CbGpPWpGaD
Fluvastatin—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000133	0.00259	CbGpPWpGaD
Fluvastatin—Diarrhoea—Etoposide—brain cancer	0.000133	0.00119	CcSEcCtD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000133	0.00259	CbGpPWpGaD
Fluvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000132	0.00257	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000131	0.00256	CbGpPWpGaD
Fluvastatin—SLCO2B1—cerebellum—brain cancer	0.00013	0.0162	CbGeAlD
Fluvastatin—Dizziness—Etoposide—brain cancer	0.000128	0.00115	CcSEcCtD
Fluvastatin—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000127	0.00249	CbGpPWpGaD
Fluvastatin—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000126	0.00245	CbGpPWpGaD
Fluvastatin—HMGCR—brain—brain cancer	0.000125	0.0155	CbGeAlD
Fluvastatin—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000124	0.00241	CbGpPWpGaD
Fluvastatin—Vomiting—Etoposide—brain cancer	0.000124	0.0011	CcSEcCtD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000123	0.0024	CbGpPWpGaD
Fluvastatin—CYP2C8—pituitary gland—brain cancer	0.000123	0.0153	CbGeAlD
Fluvastatin—Rash—Etoposide—brain cancer	0.000122	0.00109	CcSEcCtD
Fluvastatin—Dermatitis—Etoposide—brain cancer	0.000122	0.00109	CcSEcCtD
Fluvastatin—Headache—Etoposide—brain cancer	0.000122	0.00109	CcSEcCtD
Fluvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000119	0.00232	CbGpPWpGaD
Fluvastatin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000118	0.0023	CbGpPWpGaD
Fluvastatin—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000117	0.00228	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000116	0.00227	CbGpPWpGaD
Fluvastatin—Nausea—Etoposide—brain cancer	0.000115	0.00103	CcSEcCtD
Fluvastatin—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000115	0.00225	CbGpPWpGaD
Fluvastatin—CYP2D6—brainstem—brain cancer	0.000113	0.0141	CbGeAlD
Fluvastatin—CYP2B6—gonad—brain cancer	0.000113	0.014	CbGeAlD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000111	0.00216	CbGpPWpGaD
Fluvastatin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.00011	0.00214	CbGpPWpGaD
Fluvastatin—CYP2C19—endocrine gland—brain cancer	0.000109	0.0135	CbGeAlD
Fluvastatin—SLCO2B1—brain—brain cancer	0.000106	0.0131	CbGeAlD
Fluvastatin—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000104	0.00203	CbGpPWpGaD
Fluvastatin—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000103	0.00201	CbGpPWpGaD
Fluvastatin—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000101	0.00196	CbGpPWpGaD
Fluvastatin—CYP2D6—telencephalon—brain cancer	0.000101	0.0125	CbGeAlD
Fluvastatin—HMGCR—AMPK Signaling—TP53—brain cancer	9.8e-05	0.00191	CbGpPWpGaD
Fluvastatin—CYP2D6—Biological oxidations—CYP2C9—brain cancer	9.59e-05	0.00187	CbGpPWpGaD
Fluvastatin—CYP2C8—endocrine gland—brain cancer	9.53e-05	0.0118	CbGeAlD
Fluvastatin—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	9.46e-05	0.00184	CbGpPWpGaD
Fluvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	9.09e-05	0.00177	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	8.96e-05	0.00175	CbGpPWpGaD
Fluvastatin—CYP1A2—endocrine gland—brain cancer	8.91e-05	0.0111	CbGeAlD
Fluvastatin—CYP1A1—endocrine gland—brain cancer	8.79e-05	0.0109	CbGeAlD
Fluvastatin—CYP1A1—head—brain cancer	8.68e-05	0.0108	CbGeAlD
Fluvastatin—CYP3A5—endocrine gland—brain cancer	8.6e-05	0.0107	CbGeAlD
Fluvastatin—CYP2B6—endocrine gland—brain cancer	8.55e-05	0.0106	CbGeAlD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.49e-05	0.00166	CbGpPWpGaD
Fluvastatin—CYP2C9—endocrine gland—brain cancer	8.46e-05	0.0105	CbGeAlD
Fluvastatin—CYP2B6—head—brain cancer	8.44e-05	0.0105	CbGeAlD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	8.38e-05	0.00163	CbGpPWpGaD
Fluvastatin—CYP1A2—Biological oxidations—CYP2C9—brain cancer	8.12e-05	0.00158	CbGpPWpGaD
Fluvastatin—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	8.01e-05	0.00156	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—CCND1—brain cancer	7.95e-05	0.00155	CbGpPWpGaD
Fluvastatin—CYP1A1—central nervous system—brain cancer	7.92e-05	0.00983	CbGeAlD
Fluvastatin—SLCO2B1—Transmembrane transport of small molecules—TRPC6—brain cancer	7.88e-05	0.00154	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	7.87e-05	0.00154	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.81e-05	0.00152	CbGpPWpGaD
Fluvastatin—CYP2B6—central nervous system—brain cancer	7.7e-05	0.00955	CbGeAlD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	7.58e-05	0.00148	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	6.93e-05	0.00135	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	6.83e-05	0.00133	CbGpPWpGaD
Fluvastatin—CYP2C8—brain—brain cancer	6.82e-05	0.00845	CbGeAlD
Fluvastatin—HMGCR—Metabolism—CYP2C9—brain cancer	6.74e-05	0.00131	CbGpPWpGaD
Fluvastatin—CYP3A4—endocrine gland—brain cancer	6.45e-05	0.008	CbGeAlD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—brain cancer	6.38e-05	0.00124	CbGpPWpGaD
Fluvastatin—CYP2D6—endocrine gland—brain cancer	6.35e-05	0.00788	CbGeAlD
Fluvastatin—CYP1A1—brain—brain cancer	6.29e-05	0.0078	CbGeAlD
Fluvastatin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.27e-05	0.00122	CbGpPWpGaD
Fluvastatin—CYP2D6—head—brain cancer	6.27e-05	0.00778	CbGeAlD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—brain cancer	6.24e-05	0.00122	CbGpPWpGaD
Fluvastatin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.18e-05	0.00121	CbGpPWpGaD
Fluvastatin—SLCO1B3—Transmembrane transport of small molecules—TRPC6—brain cancer	6.16e-05	0.0012	CbGpPWpGaD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—TRPC6—brain cancer	6.13e-05	0.00119	CbGpPWpGaD
Fluvastatin—CYP2B6—brain—brain cancer	6.11e-05	0.00758	CbGeAlD
Fluvastatin—CYP3A4—central nervous system—brain cancer	5.81e-05	0.00721	CbGeAlD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	5.8e-05	0.00113	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—BSG—brain cancer	5.73e-05	0.00112	CbGpPWpGaD
Fluvastatin—CYP2D6—central nervous system—brain cancer	5.72e-05	0.0071	CbGeAlD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.71e-05	0.00111	CbGpPWpGaD
Fluvastatin—CYP2D6—cerebellum—brain cancer	5.59e-05	0.00694	CbGeAlD
Fluvastatin—UGT1A3—Metabolism—CYP2C9—brain cancer	5.49e-05	0.00107	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	5.34e-05	0.00104	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—brain cancer	5.24e-05	0.00102	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	5.22e-05	0.00102	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	5.22e-05	0.00102	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—CYP2C9—brain cancer	5.17e-05	0.00101	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—IDH1—brain cancer	4.92e-05	0.000961	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.89e-05	0.000954	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.83e-05	0.000943	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—CYP2C9—brain cancer	4.67e-05	0.000911	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—BSG—brain cancer	4.67e-05	0.000911	CbGpPWpGaD
Fluvastatin—CYP2D6—brain—brain cancer	4.54e-05	0.00564	CbGeAlD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.49e-05	0.000875	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—BSG—brain cancer	4.4e-05	0.000858	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.35e-05	0.000849	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.14e-05	0.000807	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—IDH1—brain cancer	4.01e-05	0.000783	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.01e-05	0.000782	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4e-05	0.000781	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—BSG—brain cancer	3.97e-05	0.000774	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—ENO2—brain cancer	3.89e-05	0.000759	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—CYP2C9—brain cancer	3.79e-05	0.00074	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—IDH1—brain cancer	3.78e-05	0.000738	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.7e-05	0.000722	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.58e-05	0.000698	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CYP2C9—brain cancer	3.48e-05	0.000678	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—IDH1—brain cancer	3.41e-05	0.000666	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.4e-05	0.000664	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.33e-05	0.00065	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.33e-05	0.00065	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.28e-05	0.00064	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—BSG—brain cancer	3.23e-05	0.000629	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—ENO2—brain cancer	3.17e-05	0.000619	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.12e-05	0.000609	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.08e-05	0.000601	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—ENO2—brain cancer	2.99e-05	0.000583	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—BSG—brain cancer	2.96e-05	0.000577	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.93e-05	0.000571	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—IDH1—brain cancer	2.77e-05	0.000541	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—ENO2—brain cancer	2.7e-05	0.000526	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.67e-05	0.000521	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—IDH1—brain cancer	2.54e-05	0.000496	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CYP2C9—brain cancer	2.36e-05	0.00046	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CYP2C9—brain cancer	2.31e-05	0.00045	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.28e-05	0.000445	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—ENO2—brain cancer	2.19e-05	0.000428	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CYP2C9—brain cancer	2.18e-05	0.000425	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.07e-05	0.000404	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—ENO2—brain cancer	2.01e-05	0.000392	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—BSG—brain cancer	2.01e-05	0.000391	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CYP2C9—brain cancer	2e-05	0.00039	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—BSG—brain cancer	1.96e-05	0.000383	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—BSG—brain cancer	1.85e-05	0.000361	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PIK3CG—brain cancer	1.79e-05	0.000348	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CYP2C9—brain cancer	1.78e-05	0.000348	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—IDH1—brain cancer	1.73e-05	0.000337	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—BSG—brain cancer	1.7e-05	0.000331	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—IDH1—brain cancer	1.69e-05	0.000329	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CYP2C9—brain cancer	1.64e-05	0.00032	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—IDH1—brain cancer	1.59e-05	0.000311	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—BSG—brain cancer	1.52e-05	0.000296	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—IDH1—brain cancer	1.46e-05	0.000285	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PIK3CG—brain cancer	1.46e-05	0.000284	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—BSG—brain cancer	1.39e-05	0.000272	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CYP2C9—brain cancer	1.39e-05	0.000271	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—BSG—brain cancer	1.38e-05	0.00027	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PIK3CG—brain cancer	1.37e-05	0.000268	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—ENO2—brain cancer	1.36e-05	0.000266	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—ENO2—brain cancer	1.33e-05	0.00026	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—IDH1—brain cancer	1.3e-05	0.000254	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.3e-05	0.000253	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ENO2—brain cancer	1.26e-05	0.000246	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PIK3CG—brain cancer	1.24e-05	0.000241	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—IDH1—brain cancer	1.2e-05	0.000234	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.19e-05	0.000232	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—IDH1—brain cancer	1.19e-05	0.000232	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—BSG—brain cancer	1.18e-05	0.00023	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ENO2—brain cancer	1.15e-05	0.000225	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CYP2C9—brain cancer	1.07e-05	0.000209	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.06e-05	0.000207	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ENO2—brain cancer	1.03e-05	0.000201	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—IDH1—brain cancer	1.02e-05	0.000198	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PIK3CG—brain cancer	1.01e-05	0.000196	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.68e-06	0.000189	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ENO2—brain cancer	9.48e-06	0.000185	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ENO2—brain cancer	9.4e-06	0.000183	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3CG—brain cancer	9.22e-06	0.00018	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—BSG—brain cancer	9.12e-06	0.000178	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.27e-06	0.000161	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ENO2—brain cancer	8.03e-06	0.000157	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—IDH1—brain cancer	7.84e-06	0.000153	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CG—brain cancer	6.26e-06	0.000122	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ENO2—brain cancer	6.2e-06	0.000121	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CG—brain cancer	6.11e-06	0.000119	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CG—brain cancer	5.78e-06	0.000113	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CG—brain cancer	5.3e-06	0.000103	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CG—brain cancer	4.73e-06	9.22e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CG—brain cancer	4.35e-06	8.48e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CG—brain cancer	4.31e-06	8.41e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CG—brain cancer	3.68e-06	7.19e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CG—brain cancer	2.84e-06	5.55e-05	CbGpPWpGaD
